APA (7th ed.) Citation

SN, A., KT, N., N, A., BR, M., & SN, G. (2026). Role of GPR55 in glutamatergic and dopaminergic signaling: A review of preclinical evidence in neuropsychiatric disorders. Molecular pharmacology, 108(5-6), 100131. https://doi.org/10.1016/j.molpha.2026.100131

Chicago Style (17th ed.) Citation

SN, Awathale, Nakhate KT, Ali N, More BR, and Goyal SN. "Role of GPR55 in Glutamatergic and Dopaminergic Signaling: A Review of Preclinical Evidence in Neuropsychiatric Disorders." Molecular Pharmacology 108, no. 5-6 (2026): 100131. https://doi.org/10.1016/j.molpha.2026.100131.

MLA (9th ed.) Citation

SN, Awathale, et al. "Role of GPR55 in Glutamatergic and Dopaminergic Signaling: A Review of Preclinical Evidence in Neuropsychiatric Disorders." Molecular Pharmacology, vol. 108, no. 5-6, 2026, p. 100131, https://doi.org/10.1016/j.molpha.2026.100131.